Rohit Sharda
Vanderbilt University Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rohit Sharda.
Diseases of The Esophagus | 2017
Dhyanesh A. Patel; Rohit Sharda; Kristen L. Hovis; E. E. Nichols; Nila A Sathe; David F. Penson; Irene D. Feurer; Melissa L McPheeters; Michael F. Vaezi; David O. Francis
OBJECTIVE Patient-reported outcome (PRO) measures are commonly used to capture patient experience with dysphagia and to evaluate treatment effectiveness. Inappropriate application can lead to distorted results in clinical studies. A systematic review of the literature on dysphagia-related PRO measures was performed to (1) identify all currently available measures and (2) to evaluate each for the presence of important measurement properties that would affect their applicability. DESIGN MEDLINE via the PubMed interface, the Cumulative Index of Nursing and Allied Health Literature, and the Health and Psychosocial Instrument database were searched using relevant vocabulary terms and key terms related to PRO measures and dysphagia. Three independent investigators performed abstract and full text reviews. Each study meeting criteria was evaluated using an 18-item checklist developed a priori that assessed multiple domains: (1) conceptual model, (2) content validity, (3) reliability, (4) construct validity, (6) scoring and interpretation, and (7) burden and presentation. RESULTS Of 4950 abstracts reviewed, a total of 34 dysphagia-related PRO measures (publication year 1987-2014) met criteria for extraction and analysis. Several PRO measures were of high quality (MADS for achalasia, SWAL-QOL and SSQ for oropharyngeal dysphagia, PROMIS-GI for general dysphagia, EORTC-QLQ-OG25 for esophageal cancer, ROMP-swallowing for Parkinsons Disease, DSQ-EoE for eosinophilic esophagitis, and SOAL for total laryngectomy-related dysphagia). In all, 17 met at least one criterion per domain. Thematic deficiencies in current measures were evident including: (1) direct patient involvement in content development, (2) empirically justified dimensionality, (3) demonstrable responsiveness to change, (4) plan for interpreting missing responses, and (5) literacy level assessment. CONCLUSION This is the first comprehensive systematic review assessing developmental properties of all available dysphagia-related PRO measures. We identified several instruments with robust measurement properties in multiple diseases including achalasia, oropharyngeal dysphagia, post-surgical dysphagia, esophageal cancer, and dysphagia related to neurological diseases. Findings herein can assist clinicians and researchers in making more informed decisions in selecting the most fundamentally sound PRO measure for a given clinical, research, or quality initiative.
Otolaryngology-Head and Neck Surgery | 2016
David O. Francis; Dhyanesh A. Patel; Rohit Sharda; Kristen L. Hovis; Nila A Sathe; David F. Penson; Irene D. Feurer; Melissa L. McPheeters; Michael F. Vaezi
Objectives Patient-reported outcome (PRO) measures are often used to diagnose laryngopharyngeal reflux (LPR) and monitor treatment outcomes in clinical and research settings. The present systematic review was designed to identify currently available LPR-related PRO measures and to evaluate each measure’s instrument development, validation, and applicability. Data Sources MEDLINE via PubMed interface, CINAHL, and Health and Psychosocial Instrument databases were searched with relevant vocabulary and key terms related to PRO measures and LPR. Review Methods Three investigators independently performed abstract review and full text review, applying a previously developed checklist to critically assess measurement properties of each study meeting inclusion criteria. Results Of 4947 studies reviewed, 7 LPR-related PRO measures (publication years, 1991-2010) met criteria for extraction and analysis. Two focused on globus and throat symptoms. Remaining measures were designed to assess LPR symptoms and monitor treatment outcomes in patients. None met all checklist criteria. Only 2 of 7 used patient input to devise item content, and 2 of 7 assessed responsiveness to change. Thematic deficiencies in current LPR-related measures are inadequately demonstrated: content validity, construct validity, plan for interpretation, and literacy level assessment. Conclusion Laryngopharyngeal reflux is often diagnosed according to symptoms. Currently available LPR-related PRO measures used to symptomatically identify suspected LPR patients have disparate developmental rigor and important methodological deficiencies. Care should be exercised to understand the measurement characteristics and contextual relevance before applying these PRO measures for clinical, research, or quality initiatives.
Alimentary Pharmacology & Therapeutics | 2018
Yash A. Choksi; James C. Slaughter; Rohit Sharda; Tina Higginbotham; Pooja Lal; Michael F. Vaezi
Symptom association probability (SAP) is thought to distinguish reflux hypersensitivity from functional disorders. A diagnosis of hypersensitive oesophagus (SAP‐positive) indicates that gastro‐oesophageal reflux disease (GERD) is the cause of continued symptoms.
Expert Review of Gastroenterology & Hepatology | 2016
Meera R. Wright; Rohit Sharda; Michael F. Vaezi
ABSTRACT Introduction: Many patients experience ear, nose and throat symptoms associated with their gastroesophageal reflux disease. These symptoms are purportedly caused by reflux of gastroduodenal contents into the larynx, which leads to laryngopharyngeal reflux (LPR). Various modalities are used to diagnose LPR, including ambulatory pH monitoring, laryngoscopy, and esophagogastroduodenoscopy, as well as a few new emerging diagnostic tests. However, there are still no established diagnostic criteria or gold standard methodologies that can reliably distinguish LPR from other conditions. Areas covered: In this review, we will evaluate currently available diagnostic tests and therapeutic options for patients with laryngeal signs and symptoms of reflux and briefly discuss the development and emergence of new treatments. Numerous studies have investigated the role of proton pump inhibitor therapy in this patient population, but have led to disparate and often inconsistent results. Expert commentary: While a subgroup of patients with LPR appears to respond to PPI therapy, many patients show no symptomatic improvement, particularly with respect to extraesophageal symptoms. As such, there is a vital need to explore alternative treatment options, including anti-reflux surgery, lifestyle changes, and other classes of medications to better address LPR.
Gastroenterology | 2016
Rohit Sharda; Yash A. Choksi; Tina Higginbotham; James C. Slaughter; Pooja Lal; Elif Saritas Yuksel; Fehmi Ates; Michael F. Vaezi
Gastroenterology | 2018
Dhyanesh A. Patel; Rohit Sharda; Yash A. Choksi; James C. Slaughter; Tina Higginbotham; C. Gaelyn Garrett; David O. Francis; Karthik Ravi; Stephen Hasak; David A. Katzka; C. Prakash Gyawali; Michael F. Vaezi
Gastroenterology | 2017
Yash A. Choksi; Rohit Sharda; Tina Higginbotham; Christopher S. Williams; Michael F. Vaezi
Gastroenterology | 2017
Rohit Sharda; Yash A. Choksi; Pooja Lal; James C. Slaughter; Tina Higginbotham; Michael F. Vaezi
Gastroenterology | 2016
Yash A. Choksi; Rohit Sharda; James C. Slaughter; Tina Higginbotham; Pooja Lal; Michael F. Vaezi
Gastroenterology | 2016
David O. Francis; Rohit Sharda; Dhyanesh A. Patel; Kristen L. Hovis; David F. Penson; Irene D. Feurer; Melissa L. McPheeters; Michael F. Vaezi